ClinicalTrials.gov
public full text
Public Domain
Miti-gene Recurrence Score in HR+/HER2- Chinese Breast Cancer Patients
Update and validate the performance of the 21-gene score in prognostic stratification for early-stage HR-positive, HER2-negative breast cancer in China.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Genotyping 2 SNPs in Chinese Breast Cancers#1093419
- the New Geneswell BCT in Vitro Diagnosis of Breast Cancer Prognosis#886038
- High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer#464561
- A machine learning framework combining cfDNA fragmentomics and serum biomarkers for early ovarian cancer detection.#297268
- Utilising Machine Learning and Single-Cell Analysis to Uncover SKCM Metastasis-Related Genes.#3732
Record · ID 830908
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive